Physician profile
Michael J Brown
NPI 1609857721
$2,248.80
in general payments reported to CMS, 2019-2025
10 companies · $197 in 2025
The $197 reported for 2025 was more than what 80% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $170 · 2020: $53.52 · 2021: $844 · 2022: $355 · 2023: $159 · 2024: $469 · 2025: $197.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $546 · Travel and Lodging: $279.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $546.32 |
| Travel and Lodging | $279.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $961.97 | 2021-2022 | |
| Abbott Laboratories | $358.84 | 2019-2023 | Mitraclip |
| Atricure, INC. | $279.39 | 2024 | |
| Edwards Lifesciences Corporation | $275.12 | 2019-2024 | Sapien 3 Ultra Resilia |
| Becton, Dickinson and Company | $125.00 | 2024 | Hemosphere |
| Braintree Laboratories, INC. | $107.44 | 2025 | Sutab, Suflave |
| Octapharma USA, INC. | $50.77 | 2025 | Fibryga |
| Merck Sharp & Dohme LLC | $38.88 | 2025 | Bridion |
| Boston Scientific Corporation | $34.70 | 2021-2024 | |
| La Jolla Pharmaceutical Company | $16.69 | 2023 | Giapreza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.